Multicomplex-based pharmacophore modeling in conjunction with multi-target docking and molecular dynamics simulations for the identification of PfDHFR inhibitors

References

• Abbat, S., Jain, V., & Bharatam, P. V. (2015). Origins of the specificity of inhibitor P218 toward wild-type and mutant Pf DHFR: A molecular dynamics analysis. Journal of Biomolecular Structure and Dynamics, 33(9), 1913–1928.
   PubMed Web of Science ®Google Scholar
• Adane, L., Bhagat, S., Arfeen, M., Bhatia, S., Sirawaraporn, R., Sirawaraporn, W., … Bharatam, P. V. (2014). Design and synthesis of guanylthiourea derivatives as potential inhibitors of Plasmodium falciparum dihydrofolate reductase enzyme. Bioorganic & Medicinal Chemistry Letters, 24(2), 613–617.
   PubMed Web of Science ®Google Scholar
• Adane, L., & Bharatam, P. V. (2009). 3D-QSAR analysis of cycloguanil derivatives as inhibitors of A16V + S108T mutant Plasmodium falciparum dihydrofolate reductase enzyme. Journal of Molecular Graphics and Modelling, 28(4), 357–367.
   PubMed Web of Science ®Google Scholar
• Adane, L., & Bharatam, P. V. (2010). Binding modes of 2, 4-diaminoquinazoline and 2, 4-diaminopteridine analogs to P. falciparum dihydrofolate reductase enzyme: Molecular docking studies. Indian Journal of Pharmaceutical Sciences, 72(3), 324.
   PubMed Web of Science ®Google Scholar
• Adane, L., & Bharatam, P. V. (2011). Computer-aided molecular design of 1H-imidazole-2, 4-diamine derivatives as potential inhibitors of Plasmodium falciparum DHFR enzyme. Journal of Molecular Modeling, 17(4), 657–667.
   PubMed Web of Science ®Google Scholar
• Adane, L., Bharatam, P. V., & Sharma, V. (2010). A common feature-based 3D-pharmacophore model generation and virtual screening: Identification of potential Pf DHFR inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry, 25(5), 635–645.
   PubMed Web of Science ®Google Scholar
• Adane, L., Patel, D., & Bharatam, P. V. (2010). Shape‐and chemical feature‐based 3D‐pharmacophore model generation and virtual screening: Identification of potential leads for P. falciparum DHFR enzyme inhibition. Chemical Biology & Drug Design, 75(1), 115–126.
   PubMed Web of Science ®Google Scholar
• Amin, S. A., Adhikari, N., Baidya, S. K., Gayen, S., & Jha, T. (in press). Structural refinement and prediction of potential CCR2 antagonists through validated multi-QSAR modeling studies. Journal of Biomolecular Structure and Dynamics. doi: 10.1080/07391102.2017.1418679
   Web of Science ®Google Scholar
• Antosiewicz, A., Jarmuła, A., Przybylska, D., Mosieniak, G., Szczepanowska, J., Kowalkowska, A., … Cieśla, J. (2017). Human dihydrofolate reductase and thymidylate synthase form a complex in vitro and co-localize in normal and cancer cells. Journal of Biomolecular Structure and Dynamics, 35(7), 1474–1490.
   PubMed Web of Science ®Google Scholar
• Athar, M., Lone, M. Y., Khedkar, V. M., & Jha, P. C. (2016). Pharmacophore model prediction, 3D-QSAR and molecular docking studies on vinyl sulfones targeting Nrf2-mediated gene transcription intended for anti-Parkinson drug design. Journal of Biomolecular Structure and Dynamics, 34(6), 1282–1297.
   PubMed Web of Science ®Google Scholar
• Berendsen, H. J., Postma, J. V., van Gunsteren, W. F., DiNola, A., & Haak, J. (1984). Molecular dynamics with coupling to an external bath. The Journal of Chemical Physics, 81(8), 3684–3690.
   Web of Science ®Google Scholar
• Bernstein, F. C., Koetzle, T. F., Williams, G. J. B., Meyer, E. F., Brice, M. D., Rodgers, J. R., … Tasumi, M. (1977). The Protein Data Bank. European Journal of Biochemistry, 80(2), 319–324.
   PubMedGoogle Scholar
• Bietz, S., Urbaczek, S., Schulz, B., & Rarey, M. (2014). Protoss: A holistic approach to predict tautomers and protonation states in protein-ligand complexes. Journal of Cheminformatics, 6(1), 12.
   PubMed Web of Science ®Google Scholar
• Böhm, H.-J. (1994). The development of a simple empirical scoring function to estimate the binding constant for a protein-ligand complex of known three-dimensional structure. Journal of Computer-Aided Molecular Design, 8(3), 243–256.
   Google Scholar
• Bowers, K. J., Chow, D. E., Xu, H., Dror, R. O., Eastwood, M. P., Gregersen, B. A., … Sacerdoti, F. D. (2006). Scalable algorithms for molecular dynamics simulations on commodity clusters. Paper presented at the Proceedings of the ACM/IEEE Conference on Supercomputing, Tampa, FL.
   Google Scholar
• Brooks, B. R., Bruccoleri, R. E., Olafson, B. D., States, D. J., Swaminathan, S., & Karplus, M. (1983). CHARMM: A program for macromolecular energy, minimization, and dynamics calculations. Journal of Computational Chemistry, 4(2), 187–217.
   Web of Science ®Google Scholar
• Carrington, H., Crowther, A., Davey, D., Levi, A., & Rose, F. (1951). A metabolite of paludrine with high antimalarial activity. Nature, 168(4288), 1080p
   PubMed Web of Science ®Google Scholar
• Cereto-Massagué, A., Guasch, L., Valls, C., Mulero, M., Pujadas, G., & Garcia-Vallvé, S. (2012). DecoyFinder: An easy-to-use python GUI application for building target-specific decoy sets. Bioinformatics (Oxford, England), 28(12), 1661–1662.
   PubMed Web of Science ®Google Scholar
• Chitnumsub, P., Yavaniyama, J., Vanichtanankul, J., Kamchonwongpaisan, S., Walkinshaw, M. D., & Yuthavong, Y. (2004). Characterization, crystallization and preliminary X‐ray analysis of bifunctional dihydrofolate reductase–thymidylate synthase from Plasmodium falciparum. Acta Crystallographica Section D Biological Crystallography, 60(4), 780–783.
   PubMedGoogle Scholar
• Chofor, R., Sooriyaarachchi, S., Risseeuw, M. D. P., Bergfors, T., Pouyez, J., Johny, C., … Van Calenbergh, S. (2015). Synthesis and bioactivity of β-substituted fosmidomycin analogues targeting 1-deoxy-D-xylulose-5-phosphate reductoisomerase. Journal of Medicinal Chemistry, 58(7), 2988–3001.
   PubMed Web of Science ®Google Scholar
• Clark, D. E., & Pickett, S. D. (2000). Computational methods for the prediction of 'drug-likeness'. Drug Discovery Today, 5(2), 49–58.
   PubMed Web of Science ®Google Scholar
• Curd, F., Davey, D., & Rose, F. (1945). Studies on synthetic antimalarial drugs: X.—Some biguanide derivatives as new types of antimalarial substances with both therapeutic and causal prophylactic activity. Annals of Tropical Medicine & Parasitology, 39(3–4), 208–216.
   PubMed Web of Science ®Google Scholar
• D. E. Shaw Research. (2016). Maestro-Desmond Interoperability Tools, Desmond Molecular Dynamics System, New York, NY. Schrödinger, New York, NY.
   Google Scholar
• Darden, T., York, D., & Pedersen, L. (1993). Particle mesh Ewald: An N⋅ log (N) method for Ewald sums in large systems. The Journal of Chemical Physics, 98(12), 10089–10092.
   Web of Science ®Google Scholar
• Dasgupta, T., Chitnumsub, P., Kamchonwongpaisan, S., Maneeruttanarungroj, C., Nichols, S. E., Lyons, T. M., … Anderson, K. S. (2009). Exploiting structural analysis, in silico screening, and serendipity to identify novel inhibitors of drug-resistant falciparum malaria. ACS Chemical Biology, 4(1), 29–40.
   PubMed Web of Science ®Google Scholar
• de Souza, F. R., Guimarães, A. P., Cuya, T., de Freitas, M. P., Gonçalves, A. D S., Forgione, P., & Costa França, T. C. (2017). Analysis of Coxiela burnetti dihydrofolate reductase via in silico docking with inhibitors and molecular dynamics simulation. Journal of Biomolecular Structure and Dynamics, 35(13), 2975–2986.
   PubMed Web of Science ®Google Scholar
• Discovery Studio version 4.0. San Diego, CA: Accelrys Software, Inc. Retrieved from www.accelrys.com/products/collaborativescience/biovia-discovery-studio/
   Google Scholar
• Egieyeh, S. A., Syce, J., Malan, S. F., & Christoffels, A. (2016). Prioritization of anti-malarial hits from nature: Chemo-informatic profiling of natural products with in vitro antiplasmodial activities and currently registered anti-malarial drugs. Malaria Journal, 15(1), 50.
   PubMed Web of Science ®Google Scholar
• Gaulton, A., Bellis, L. J., Bento, A. P., Chambers, J., Davies, M., Hersey, A., … Overington, J. P. (2012). ChEMBL: A large-scale bioactivity database for drug discovery. Nucleic Acids Research, 40(D1), D1100–D1107.
   PubMed Web of Science ®Google Scholar
• Gregson, A., & Plowe, C. V. (2005). Mechanisms of resistance of malaria parasites to antifolates. Pharmacological Reviews, 57(1), 117–145.
   PubMed Web of Science ®Google Scholar
• Güner, O. F. (2000). Pharmacophore perception, development, and use in drug design. La Jolla, CA: Internat'l University Line.
   Google Scholar
• Harinasuta, T., Suntharasamai, P., & Viravan, C. (1965). Chloroquine-resistant falciparum malaria in Thailand. Lancet (London, England)), 2(7414), 657–660.
   PubMed Web of Science ®Google Scholar
• Head, J. D., & Zerner, M. C. (1985). A Broyden—Fletcher—Goldfarb—Shanno optimization procedure for molecular geometries. Chemical Physics Letters, 122(3), 264–270.
   Web of Science ®Google Scholar
• Hunt, S. Y., Detering, C., Varani, G., Jacobus, D. P., Schiehser, G. A., Shieh, H.-M., … Sibley, C. H. (2005). Identification of the optimal third generation antifolate against P. falciparum and P. vivax. Molecular and Biochemical Parasitology, 144(2), 198–205.
   PubMed Web of Science ®Google Scholar
• Jana, S., & Singh, S. K. (2018). Identification of selective MMP-9 inhibitors through multiple e-pharmacophore, ligand-based pharmacophore, molecular docking, and density functional theory approaches. Journal of Biomolecular Structure and Dynamics, 9, 1–22.
   Web of Science ®Google Scholar
• Japrung, D., Leartsakulpanich, U., Chusacultanachai, S., & Yuthavong, Y. (2007). Conflicting requirements of Plasmodium falciparum dihydrofolate reductase mutations conferring resistance to pyrimethamine-WR99210 combination. Antimicrobial Agents and Chemotherapy, 51(12), 4356–4360.
   PubMed Web of Science ®Google Scholar
• Jorgensen, W. L., Chandrasekhar, J., Madura, J. D., Impey, R. W., & Klein, M. L. (1983). Comparison of simple potential functions for simulating liquid water. The Journal of Chemical Physics, 79(2), 926–935.
   Web of Science ®Google Scholar
• Jorgensen, W. L., Maxwell, D. S., & Tirado-Rives, J. (1996). Development and testing of the OPLS all-atom force field on conformational energetics and properties of organic liquids. Journal of the American Chemical Society, 118(45), 11225–11236.
   Web of Science ®Google Scholar
• Kamchonwongpaisan, S., Quarrell, R., Charoensetakul, N., Ponsinet, R., Vilaivan, T., Vanichtanankul, J., … Yuthavong, Y. (2004). Inhibitors of multiple mutants of Plasmodium falciparum dihydrofolate reductase and their antimalarial activities. Journal of Medicinal Chemistry, 47(3), 673–680.
   PubMed Web of Science ®Google Scholar
• Kaur, K., Jain, M., Kaur, T., & Jain, R. (2009). Antimalarials from nature. Bioorganic & Medicinal Chemistry, 17(9), 3229–3256.
   PubMed Web of Science ®Google Scholar
• Kontoyianni, M., McClellan, L. M., & Sokol, G. S. (2004). Evaluation of docking performance: Comparative data on docking algorithms. Journal of Medicinal Chemistry, 47(3), 558–565.
   PubMed Web of Science ®Google Scholar
• Konzuch, S., Umeda, T., Held, J., Hähn, S., Brücher, K., Lienau, C., … Kurz, T. (2014). Binding modes of reverse fosmidomycin analogs toward the antimalarial target IspC. Journal of Medicinal Chemistry, 57(21), 8827–8838.
   PubMed Web of Science ®Google Scholar
• Kunfermann, A., Lienau, C., Illarionov, B., Held, J., Gräwert, T., Behrendt, C. T., … Kurz, T. (2013). IspC as target for antiinfective drug discovery: Synthesis, enantiomeric separation, and structural biology of fosmidomycin thia isosters. Journal of Medicinal Chemistry, 56(20), 8151–8162.
   PubMed Web of Science ®Google Scholar
• Lambrakos, S., Boris, J., Oran, E., Chandrasekhar, I., & Nagumo, M. (1989). A modified shake algorithm for maintaining rigid bonds in molecular dynamics simulations of large molecules. Journal of Computational Physics, 85(2), 473–486.
   Web of Science ®Google Scholar
• LeadIT version 2.1.8. BioSolveIT GmbH, Sankt Augustin, Germany. Retrieved from www.biosolveit.de/LeadIT
   Google Scholar
• Lemcke, T., Christensen, I. T., & Jørgensen, F. S. (1999). Towards an understanding of drug resistance in malaria: Three-dimensional structure of Plasmodium falciparum dihydrofolate reductase by homology building. Bioorganic & Medicinal Chemistry, 7(6), 1003–1011.
   PubMed Web of Science ®Google Scholar
• Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 23(1-3), 3–25.
   Web of Science ®Google Scholar
• Lone, M. Y., Athar, M., Gupta, V. K., & Jha, P. C. (2017a). Identification of Mycobacterium tuberculosis enoyl-acyl carrier protein reductase inhibitors: A combined in-silico and in-vitro analysis. Journal of Molecular Graphics and Modelling, 76, 172–180.
   PubMed Web of Science ®Google Scholar
• Lone, M. Y., Athar, M., Gupta, V. K., & Jha, P. C. (2017b). Prioritization of natural compounds against mycobacterium tuberculosis 3-dehydroquinate dehydratase: A combined in-silico and in-vitro study. Biochemical and Biophysical Research Communications, 491(4), 1105–1111.
   PubMed Web of Science ®Google Scholar
• Lone, M. Y., Kumar, S. P., Athar, M., & Jha, P. C. (2018). Exploration of Mycobacterium tuberculosis structural proteome: An in-silico approach. Journal of Theoretical Biology, 439, 14–23.
   PubMed Web of Science ®Google Scholar
• Lone, M. Y., Manhas, A., Athar, M., & Jha, P. C. (2017). Identification of InhA inhibitors: A combination of virtual screening, molecular dynamics simulations and quantum chemical studies. Journal of Biomolecular Structure and Dynamics, 36(11), 2951–2965.
   PubMed Web of Science ®Google Scholar
• Lu, S.-H., Wu, J. W., Liu, H.-L., Zhao, J.-H., Liu, K.-T., Chuang, C.-K., … Ho, Y. (2011). The discovery of potential acetylcholinesterase inhibitors: A combination of pharmacophore modeling, virtual screening, and molecular docking studies. Journal of Biomedical Science, 18(1), 8.
   PubMed Web of Science ®Google Scholar
• Manhas, A., Kumar, S. P., & Jha, P. C. (2016). Molecular modeling of Plasmodium falciparum peptide deformylase and structure-based pharmacophore screening for inhibitors. RSC Advances, 6(35), 29466–29485.
   Web of Science ®Google Scholar
• Manhas, A., Lone, M. Y., & Jha, P. C. (2017). Multicomplex-based pharmacophore modeling coupled with molecular dynamics simulations: An efficient strategy for the identification of novel inhibitors of PfDHODH. Journal of Molecular Graphics and Modelling, 75, 413–430.
   PubMed Web of Science ®Google Scholar
• Manhas, A., Lone, M. Y., & Jha, P. C. (in press). In search of the representative pharmacophore hypotheses of the enzymatic proteome of Plasmodium falciparum: A multicomplex-based approach. Molecular Diversity. doi: 10.1007/s11030-018-9885-5
   Web of Science ®Google Scholar
• Manhas, A., Patel, A., Lone, M. Y., Jha, P. K., & Jha, P. C. (2018). Identification of PfENR inhibitors: A hybrid structure‐based approach in conjunction with molecular dynamics simulations. Journal of Cellular Biochemistry, 119(10), 8490–8500.
   PubMed Web of Science ®Google Scholar
• Martyna, G. J., Tobias, D. J., & Klein, M. L. (1994). Constant pressure molecular dynamics algorithms. The Journal of Chemical Physics, 101(5), 4177–4189.
   Web of Science ®Google Scholar
• McKie, J. H., Douglas, K. T., Chan, C., Roser, S. A., Yates, R., Read, M., … Sirawaraporn, W. (1998). Rational drug design approach for overcoming drug resistance: Application to pyrimethamine resistance in malaria. Journal of Medicinal Chemistry, 41(9), 1367–1370.
   PubMed Web of Science ®Google Scholar
• Modi, P., Patel, S., & Chhabria, M. T. (2018). Identification of some novel pyrazolo [1, 5-a] pyrimidine derivatives as InhA inhibitors through pharmacophore-based virtual screening and molecular docking. Journal of Biomolecular Structure and Dynamics, 4, 1–14.
   Web of Science ®Google Scholar
• Nogueira, C. R., & Lopes, L. M. (2011). Antiplasmodial natural products. Molecules, 16(3), 2146–2190.
   Web of Science ®Google Scholar
• Nosé, S. (1984). A unified formulation of the constant temperature molecular dynamics methods. The Journal of Chemical Physics, 81(1), 511–519.
   Web of Science ®Google Scholar
• Nzila, A., Rottmann, M., Chitnumsub, P., Kiara, S. M., Kamchonwongpaisan, S., Maneeruttanarungroj, C., … Diagana, T. T. (2010). Preclinical evaluation of the antifolate QN254, 5-chloro-N′ 6′-(2, 5-dimethoxy-benzyl)-quinazoline-2, 4, 6-triamine, as an antimalarial drug candidate. Antimicrobial Agents and Chemotherapy, 54(6), 2603–2610.
   PubMed Web of Science ®Google Scholar
• Osborne, M. J., Schnell, J., Benkovic, S. J., Dyson, H. J., & Wright, P. E. (2001). Backbone dynamics in dihydrofolate reductase complexes: Role of loop flexibility in the catalytic mechanism. Biochemistry, 40(33), 9846–9859.
   PubMed Web of Science ®Google Scholar
• Parenti, M. D., Pacchioni, S., Ferrari, A. M., & Rastelli, G. (2004). Three-dimensional quantitative structure − activity relationship analysis of a set of Plasmodium falciparum dihydrofolate reductase inhibitors using a pharmacophore generation approach. Journal of Medicinal Chemistry, 47(17), 4258–4267.
   PubMed Web of Science ®Google Scholar
• Phillipson, J. D. (2001). Phytochemistry and medicinal plants. Phytochemistry, 56(3), 237–243.
   PubMed Web of Science ®Google Scholar
• Rarey, M., Kramer, B., & Lengauer, T. (1997). Multiple automatic base selection: Protein–ligand docking based on incremental construction without manual intervention. Journal of Computer-Aided Molecular Design, 11(4), 369–384.
   PubMed Web of Science ®Google Scholar
• Rarey, M., Kramer, B., Lengauer, T., & Klebe, G. (1996). A fast flexible docking method using an incremental construction algorithm. Journal of Molecular Biology, 261(3), 470–489.
   PubMed Web of Science ®Google Scholar
• Rastelli, G., Pacchioni, S., Sirawaraporn, W., Sirawaraporn, R., Parenti, M. D., & Ferrari, A. M. (2003). Docking and database screening reveal new classes of Plasmodium falciparum dihydrofolate reductase inhibitors. Journal of Medicinal Chemistry, 46(14), 2834–2845.
   PubMed Web of Science ®Google Scholar
• Rastelli, G., Sirawaraporn, W., Sompornpisut, P., Vilaivan, T., Kamchonwongpaisan, S., Quarrell, R., … Yuthavong, Y. (2000). Interaction of pyrimethamine, cycloguanil, WR99210 and their analogues with Plasmodium falciparum dihydrofolate reductase: Structural basis of antifolate resistance. Bioorganic & Medicinal Chemistry, 8(5), 1117–1128.
   PubMed Web of Science ®Google Scholar
• Sardarian, A., Douglas, K. T., Read, M., Sims, P. F. G., Hyde, J. E., Chitnumsub, P., … Sirawaraporn, W. (2003). Pyrimethamine analogs as strong inhibitors of double and quadruple mutants of dihydrofolate reductase in human malaria parasites. Organic & Biomolecular Chemistry, 1(6), 960–964.
   PubMed Web of Science ®Google Scholar
• Saxena, S., Abdullah, M., Sriram, D., & Guruprasad, L. (2017). Discovery of novel inhibitors of Mycobacterium tuberculosis MurG: Homology modelling, structure based pharmacophore, molecular docking, and molecular dynamics simulations. Journal of Biomolecular Structure and Dynamics, 17, 1–15.
   Google Scholar
• Saxena, S., Durgam, L., & Guruprasad, L. (2018). Multiple e-pharmacophore modelling pooled with high-throughput virtual screening, docking and molecular dynamics simulations to discover potential inhibitors of Plasmodium falciparum lactate dehydrogenase (PfLDH). Journal of Biomolecular Structure and Dynamics, 14, 1–17.
   Web of Science ®Google Scholar
• Sirawaraporn, W., Prapunwattana, P., Sirawaraporn, R., Yuthavong, Y., & Santi, D. (1993). The dihydrofolate reductase domain of Plasmodium falciparum thymidylate synthase-dihydrofolate reductase. Gene synthesis, expression, and anti-folate-resistant mutants. Journal of Biological Chemistry, 83(1), 93–21644.
   Google Scholar
• Sirichaiwat, C., Intaraudom, C., Kamchonwongpaisan, S., Vanichtanankul, J., Thebtaranonth, Y., & Yuthavong, Y. (2004). Target guided synthesis of 5-benzyl-2, 4-diamonopyrimidines: Their antimalarial activities and binding affinities to wild type and mutant dihydrofolate reductases from Plasmodium falciparum. Journal of Medicinal Chemistry, 47(2), 345–354.
   PubMed Web of Science ®Google Scholar
• Snow, R. W., Guerra, C. A., Noor, A. M., Myint, H. Y., & Hay, S. I. (2005). The global distribution of clinical episodes of Plasmodium falciparum malaria. Nature, 434(7030), 214.
   PubMed Web of Science ®Google Scholar
• Sooriyaarachchi, S., Chofor, R., Risseeuw, M. D. P., Bergfors, T., Pouyez, J., Dowd, C. S., … Mowbray, S. L. (2016). Targeting an aromatic hotspot in Plasmodium falciparum 1‐deoxy‐d‐xylulose‐5‐phosphate reductoisomerase with β‐arylpropyl analogues of fosmidomycin. ChemMedChem, 11(18), 2024–2036.
   PubMed Web of Science ®Google Scholar
• SPECS and BioSPECS. (2016). Retrieved from http://www.specs.net/.
   Google Scholar
• Stierand, K., & Rarey, M. (2010). Drawing the PDB: Protein-ligand complexes in two dimensions. ACS Medicinal Chemistry Letters, 1(9), 540–545.
   PubMed Web of Science ®Google Scholar
• SYBYL. (1994). TRIPOS Associates Inc, St. Louis, Missouri, USA. Retrieved from http://www.tripos.com/.
   Google Scholar
• Tan, D. S. (2004). Current progress in natural product-like libraries for discovery screening. Combinatorial Chemistry & High Throughput Screening, 7(7), 631–643.
   PubMed Web of Science ®Google Scholar
• Tuckerman, M., Berne, B. J., & Martyna, G. J. (1992). Reversible multiple time scale molecular dynamics. The Journal of Chemical Physics, 97(3), 1990–2001.
   Web of Science ®Google Scholar
• Umeda, T., Tanaka, N., Kusakabe, Y., Nakanishi, M., Kitade, Y., & Nakamura, K. T. (2011). Molecular basis of fosmidomycin's action on the human malaria parasite Plasmodium falciparum. Scientific Reports, 1, 9.
   PubMed Web of Science ®Google Scholar
• Vanichtanankul, J., Taweechai, S., Uttamapinant, C., Chitnumsub, P., Vilaivan, T., Yuthavong, Y., & Kamchonwongpaisan, S. (2012). Combined spatial limitation around residues 16 and 108 of Plasmodium falciparum dihydrofolate reductase explains resistance to cycloguanil. Antimicrobial Agents and Chemotherapy, 56(7), 3928–3935.
   PubMed Web of Science ®Google Scholar
• Vanichtanankul, J., Taweechai, S., Yuvaniyama, J., Vilaivan, T., Chitnumsub, P., Kamchonwongpaisan, S., & Yuthavong, Y. (2011). Trypanosomal dihydrofolate reductase reveals natural antifolate resistance. ACS Chemical Biology, 6(9), 905–911.
   PubMed Web of Science ®Google Scholar
• Veber, D. F., Johnson, S. R., Cheng, H.-Y., Smith, B. R., Ward, K. W., & Kopple, K. D. (2002). Molecular properties that influence the oral bioavailability of drug candidates. Journal of Medicinal Chemistry, 45(12), 2615–2623.
   PubMed Web of Science ®Google Scholar
• Vyas, V. K., Ghate, M., & Goel, A. (2013). Pharmacophore modeling, virtual screening, docking and in silico ADMET analysis of protein kinase B (PKB β) inhibitors. Journal of Molecular Graphics and Modelling, 42, 17–25.
   PubMed Web of Science ®Google Scholar
• Wang, N., Ren, J.-X., & Xie, Y. (2018). Identification of novel DHFR inhibitors for treatment of tuberculosis by combining virtual screening with in vitro activity assay. Journal of Biomolecular Structure and Dynamics, 6, 1–8.
   Web of Science ®Google Scholar
• Wang, Y., Yang, L., Hou, J., Zou, Q., Gao, Q., Yao, W., … Zhang, J. (2018). Hierarchical virtual screening of the dual MMP-2/HDAC-6 inhibitors from natural products based on pharmacophore models and molecular docking. Journal of Biomolecular Structure and Dynamics, 12, 1–22.
   Web of Science ®Google Scholar
• Warhurst, D. C. (1998). Antimalarial drug discovery: Development of inhibitors of dihydrofolate reductase active in drug resistance. Drug Discovery Today, 3(12), 538–546.
   Web of Science ®Google Scholar
• Warhurst, D. C. (2002). Resistance to antifolates in Plasmodium falciparum, the causative agent of tropical malaria. Science Progress, 85(1), 89–111.
   PubMedGoogle Scholar
• Wells, T. N. (2011). Natural products as starting points for future anti-malarial therapies: Going back to our roots?. Malaria Journal, 10(Suppl 1), S3.
   PubMed Web of Science ®Google Scholar
• White, N. J. (2004). Antimalarial drug resistance. The Journal of Clinical Investigation, 113(8), 1084–1092.
   PubMed Web of Science ®Google Scholar
• WHO. (2016). World Health Organization, World Malaria Report 2016. Geneva, Switzerland: Author.
   Google Scholar
• Xue, J., Diao, J., Cai, G., Deng, L., Zheng, B., Yao, Y., & Song, Y. (2013). Antimalarial and structural studies of pyridine-containing inhibitors of 1-deoxyxylulose-5-phosphate reductoisomerase. ACS Medicinal Chemistry Letters, 4(2), 278–282.
   PubMed Web of Science ®Google Scholar
• Yuthavong, Y., Tarnchompoo, B., Vilaivan, T., Chitnumsub, P., Kamchonwongpaisan, S., Charman, S. A., … Matthews, D. (2012). Malarial dihydrofolate reductase as a paradigm for drug development against a resistance-compromised target. Proceedings of the National Academy of Sciences, 109(42), 16823–16828.
   PubMed Web of Science ®Google Scholar
• Yuthavong, Y., Vilaivan, T., Chareonsethakul, N., Kamchonwongpaisan, S., Sirawaraporn, W., Quarrell, R., & Lowe, G. (2000). Development of a lead inhibitor for the A16V + S108T mutant of dihydrofolate reductase from the cycloguanil-resistant strain (T9/94) of Plasmodium falciparum. Journal of Medicinal Chemistry, 43(14), 2738–2744.
   PubMed Web of Science ®Google Scholar
• Yuthavong, Y., Yuvaniyama, J., Chitnumsub, P., Vanichtanankul, J., Chusacultanachai, S., Tarnchompoo, B., … Kamchonwongpaisan, S. (2005). Malarial (Plasmodium falciparum) dihydrofolate reductase-thymidylate synthase: Structural basis for antifolate resistance and development of effective inhibitors. Parasitology, 130(3), 249–259.
   PubMed Web of Science ®Google Scholar
• Yuvaniyama, J., Chitnumsub, P., Kamchonwongpaisan, S., Vanichtanankul, J., Sirawaraporn, W., Taylor, P., … Yuthavong, Y. (2003). Insights into antifolate resistance from malarial DHFR-TS structures. Nature Structural & Molecular Biology, 10(5), 357–365.
   Web of Science ®Google Scholar